Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

NCT04146181 ·Status: UNKNOWN ·Phase: PHASE2

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

NCT01914900 ·Status: COMPLETED ·Phase: PHASE2

Study of SCB01A in Patient With Head and Neck Cancer

NCT02488629 ·Status: TERMINATED ·Phase: PHASE2

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

NCT03121313 ·Status: UNKNOWN ·Phase: PHASE2

Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience

NCT05950737 ·Status: COMPLETED ·Phase: NA

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

NCT02923258 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

NCT05125055 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

NCT02290145 ·Status: RECRUITING ·Phase: PHASE2

WGA in Platinum-refractory HNSCC Underwent Nivolumab

NCT03917537 ·Status: UNKNOWN

Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial

NCT04413214 ·Status: COMPLETED ·Phase: PHASE1

Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

NCT00201383 ·Status: COMPLETED ·Phase: PHASE3

Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers

NCT04086849 ·Status: COMPLETED

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

NCT06895369 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions

NCT05327270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma

NCT06576180 ·Status: RECRUITING

Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）

NCT06011993 ·Status: UNKNOWN

Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas

NCT06236464 ·Status: RECRUITING

Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

NCT02507141 ·Status: RECRUITING

PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation

NCT03163797 ·Status: UNKNOWN

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

NCT06081582 ·Status: RECRUITING ·Phase: PHASE2

The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma

NCT02916368 ·Status: UNKNOWN

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma

NCT06575322 ·Status: RECRUITING

Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC

NCT04659369 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

NCT01606566 ·Status: TERMINATED ·Phase: PHASE2

Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT04361409 ·Status: COMPLETED ·Phase: PHASE1